Skip to main content

Ezose, Fast Forward Team on MS Biomarker Research

NEW YORK (GenomeWeb News) – Ezose Sciences today said that it will collaborate with Fast Forward, a subsidiary of the National Multiple Sclerosis Society, to discover biomarkers that may help diagnose multiple sclerosis, improve disease management, and help guide development of new MS medicines.

Under the alliance, Ezose will collaborate with Anthony Reder, a professor of neurology at the University of Chicago. Researchers will use Ezose's GlycanMap to discover new biomarkers associated with MS. The GlycanMap platform combines high-throughput glycan enrichment with specialized MALDI-TOF mass spectrometry and bioinformatics to identify and quantitate glycans in complex biological samples.

Pine Brook, NJ-based Ezose said that it will receive up to $390,000 from Fast Forward to support the studies. Further terms were not disclosed.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.